Clinical Trials on Inverse Psoriasis in Germany

Total 411 results

LEO Pharma

Completed

Trial Twice Daily Application of LEO 124249 Ointment 30 mg/g in Treatment of Mild to Moderate Inverse Psoriasis

Inverse Psoriasis

Germany
selectION Therapeutics GmbH
FGK Clinical Research GmbH

Recruiting

A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris or Psoriatic Arthritis

Psoriasis Vulgaris | Psoriatic Arthritis

Germany
Bristol-Myers Squibb

Completed

Safety and Effectiveness of Abatacept in Psoriatic Arthritis Participants (ALTEA)

Psoriatic Arthritis (PsA)

Germany
Universitätsklinikum Hamburg-Eppendorf
Bristol-Myers Squibb; Eli Lilly and Company; UCB Pharma; Merck Sharp & Dohme LLC; AbbVi... and other collaborators

Recruiting

PsoBest - The German Psoriasis Registry

Psoriasis | Psoriatic-arthritis

Germany
AbbVie
Boehringer Ingelheim

Completed

This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic Arthritis

Psoriasis

Germany
University of Erlangen-Nürnberg Medical School

Completed

Psoriasis-Arthritis & Bone Program (PSARTROS)

Psoriasis | Psoriatic Arthritis

Germany
University of Erlangen-Nürnberg Medical School

Recruiting

Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis

Psoriatic Arthritis | Withdrawal | Reduction

Germany
Dr. Frank Behrens
Janssen-Cilag Ltd.

Completed

Impact of Concomitant MTX on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active PsA (MUST)

Psoriatic Arthritis

Germany
Charite University, Berlin, Germany
Assessment of Spondyloarthritis International Society (ASAS); Group for Research...

Recruiting

Axial Involvement in Psoriatic Arthritis Cohort (AXIS)

Psoriatic Arthritis

Canada, Germany
University of Erlangen-Nürnberg Medical School

Unknown

Abatacept Bone Effects in Psoriatic Arthritis With Bone Biomarker

Evaluate Bone Changes in Patients With PsA

Germany
Pfizer

Completed

Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists

Psoriasis | Skin Diseases, Papulosquamous | Arthritis, Psoriatic

Germany
Pfizer

Completed

Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists

Psoriasis | Skin Diseases, Papulosquamous | Arthritis, Psoriatic

Germany
UCB Biopharma SRL

Completed

A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis (BE READY)

Psoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque Psoriasis

United States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, United Kingdom
Novartis Pharmaceuticals

Completed

Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis

Psoriatic Arthritis

Germany, Netherlands, United Kingdom
LEO Pharma

Completed

Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation

Plaque Psoriasis | Psoriasis Vulgaris

Germany
University of Erlangen-Nürnberg Medical School

Active, not recruiting

EBIO - Enthesitis Biopsy Study (EBIO)

Psoriatic Arthritis | Enthesitis | Biopsy

Germany
Amgen

Completed

Study of Apremilast Use in Patients With Psoriatic Arthritic in Practice Conditions (LAPIS-PsA)

Arthritis, Psoriatic

Germany
UCB Biopharma SRL

Completed

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis (BE VIVID)

Psoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque Psoriasis

United States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Poland, Russian Federation, United Kingdom
Novartis Pharmaceuticals

Completed

Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis

Psoriatic Arthritis

Germany, Netherlands, United Kingdom
LEO Pharma

Completed

Efficacy and Tolerability of Enstilar® in Daily Practice

Plaque Psoriasis

Germany
Pfizer

Completed

A 12 Day Study To Evaluate A Topical Drug To Treat Plaque Psoriasis

Psoriasis Vulgaris

Germany
LEO Pharma

Completed

Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)

Scalp Psoriasis

Germany
Zalicus
Bioskin GmbH

Completed

Study of CRx-191 to Assess Activity in Plaque Psoriasis

Plaque Psoriasis

Germany
LEO Pharma

Completed

LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris

Psoriasis Vulgaris

Germany
Philips Electronics Nederland BV

Completed

Blue Light for Treating Psoriasis Vulgaris

Psoriasis Vulgaris

Germany
LEO Pharma
LEO Pharma GmbH, Neu-Isenburg, Germany

Completed

Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris

Psoriasis Vulgaris

Germany
Technische Universität Dresden

Unknown

Investigation of Antipsoriatic Effects of UVB-induced Synthesis of 1alpha, 25-Dihydroxyvitamin D3 (1alpha, 25(OH)2D3, Calcitriol)in Keratinocytes of Psoriatic Skin, Using Cytochrom-P(CYP)Inhibitor Ketokonazol (VITAKET)

Psoriasis Vulgaris

Germany
Eisai Limited

Completed

A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris

Psoriasis Vulgaris

Germany
Philips Electronics Nederland BV

Completed

Efficacy and Safety of Blue Light (453 nm) Treatment for Mild Psoriasis Vulgaris Over Three Months Compared to Vitamin D.

Psoriasis Vulgaris

Germany
Almirall, S.A.

Active, not recruiting

Observational Real-world Evidence (RWE) Study to Assess Patient-reported Wellbeing Using Tildrakizumab in Live Setting - POSITIVE Study (POSITIVE)

Plaque Psoriasis

Germany
Circassia Limited
Bioskin GmbH

Completed

Antipsoriatic Effect of a Topical Formulation for the Treatment of Psoriasis Vulgaris

Psoriasis Vulgaris

Germany
Technische Universität Dresden

Completed

Evaluation of Topical Antipsoriatics in the Psoriasis Plaque Test

Psoriasis Vulgaris

Germany
Cantargia AB

Recruiting

A Study to Investigate the Safety and Tolerability of CAN10 Antibody in Healthy Subjects and in Subjects With Plaque Psoriasis.

Healthy | Plaque Psoriasis

Germany
Charite University, Berlin, Germany
German Heart Center

Completed

Tissue Sodium in Patients With Psoriasis (TSS1)

Healthy | Psoriasis Vulgaris

Germany
Forward-Pharma GmbH

Completed

Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

Germany
Almirall, S.A.

Completed

Efficacy and Safety of Tazarotene Gel in Nail Psoriasis

Nail Psoriasis

Germany
Pfizer

Completed

Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis

Plaque Psoriasis

Germany
G. Pohl-Boskamp GmbH & Co. KG
Universitätsklinikum Hamburg-Eppendorf

Completed

Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis Capitis

Scalp Psoriasis

Germany
Novartis Pharmaceuticals

Active, not recruiting

Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment (AgAIN)

Psoriatic Arthritis

Germany
Ruhr University of Bochum

Completed

Topical Vitamin B12 in Chronic Plaque Psoriasis

Chronic Plaque Psoriasis

Germany
Lipidor AB
Bioskin GmbH

Completed

Efficacy and Safety of Novel Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis (AKVANO-AKP01)

Psoriasis Vulgaris

Germany
Prof. Kristian Reich

Completed

Trial in Patients With Psoriasis Treated With Methotrexate Using an Optimized Treatment Schedule (METOP) (METOP)

Psoriasis Vulgaris

Germany
Charite University, Berlin, Germany
Biogen

Completed

Safety and Tolerability of Repeat Courses of IM Alefacept

Chronic Plaque Psoriasis

Germany
Zalicus

Completed

A Single-Center Exploratory Study to Assess the Activity of CRx-197-002 in Plaque Psoriasis (197-002)

Plaque Psoriasis

Germany
Diamant Thaci
Novartis

Completed

Exploratory Evaluation of Biomarkers Associated With Treatment Response to Cosentyx (Secukinumab) in Psoriasis Patients (BIOMARKER)

Psoriasis Vulgaris

Germany
LEO Pharma

Completed

Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamics Effect of Calcipotriol/Betamethasone Dipropionate in a New Administration Form in Subjects With Chronic Plaque Psoriasis.

Psoriasis Vulgaris

Germany
Covagen

Terminated

Safety and Tolerability Study of COVA322 in Patients With Stable Chronic Moderate-to-severe Plaque Psoriasis

Plaque Psoriasis

Germany
University of Oxford
Amgen

Recruiting

AsseSSing Impact in pSoriatic Treatment (ASSIST)

Psoriatic Arthritis

Spain, France, United Kingdom, Germany, Italy
MetrioPharm AG
Parexel

Completed

Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients

Psoriasis | Plaque Psoriasis

Germany
MC2 Therapeutics

Completed

This Trial is a Randomised, Multicentre, Investigator-blind, Vehicle and Comparator-controlled, Parallel-group Trial With the Purpose of Evaluation Efficacy, Safety and Convenience of the MC2-01 Cream

Psoriasis Vulgaris

Germany, Czechia

3

Subscribe